Back to MW Marshall Wace, LLP

ELAN

Showing 8 of 28 quarters

Position history for MWMarshall Wace, LLP's holdings in Elanco Animal Health Incorporated

Yes. Marshall Wace holds 4,432,350 shares of ELAN (Elanco Animal Health), worth $109.1M, as of its Q2 2026 13F filing. It increased the position from 1,382,412 shares in Q1 2026. Marshall Wace has held ELAN since Q1 2026, across 2 quarterly 13F filings. ELAN is 0.1% of Marshall Wace's reported 13F portfolio.

Current Value

$109.1M

Current Shares

4.4M

Total Value Change

+$103.2M

Total Shares Change

+4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
4.4M
+220.6%
$109.1M0.1%$24.61
48
2026-Q1
New
1.4M
-
$33.1M0.0%$23.93
40
2025-Q4
Exited
0
-100.0%
$00.0%$22.63
0
2025-Q3
Increased
367,344
+3.4%
$7.4M0.0%$20.14
28
2025-Q2
Decreased
355,266
-30.3%
$5.1M0.0%$14.28
0
2025-Q1
Increased
509,581
+203.6%
$5.4M0.0%$10.50
44
2024-Q4
Decreased
167,823
-57.9%
$2M0.0%$12.11
0
2024-Q3
Decreased
398,499
-71.2%
$5.9M0.0%$14.69
0

Other major holders of ELAN: Dodge & Cox, T. Rowe Price Associates, Inc.

Optional analytics helps us improve. How it’s used